Does surgery trigger metastasis spread in melanoma?;La chirurgie favorise-t-elle le developpement de metastases dans les melanomes?

Annales de Chirurgie Plastique Esthetique

Volumn 45, Issue 4, 2000, Pages 485-493

  Pinsolle, V ^a   Ravaud, A ^b   Baudet, J ^a  

^a HÔPITAL PELLEGRIN   (France)

^b INSTITUT BERGONIÉ   (France)

Author keywords

Cancer; Growth; Melanoma; Metastasis; Surgery

Indexed keywords

ANGIOGENESIS; HUMAN; IATROGENIC DISEASE; MEDICAL INFORMATION; MELANOMA; METASTASIS; REVIEW; SURGICAL STRESS; TUMOR GROWTH;

EID: 0033854887     PISSN: 02941260     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Does surgery disseminate or accelerate cancer?
2. Angiogenesis in cancer, vascular, rheumatoid and other disease
3. Does surgical removal of primary melanoma trigger growth of occult metastases?
4. Metastasis: Quantitative analysis of the distribution and fate of tumour emboli labeled with 125 I-5-iodo2'-deoxyuridine
5. La metastase des cancers
6. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
7. The tumour dormant state
8. Multistep nature of metastatic inefficiency. Dormancy of solitary cells after succesful extravasation and limited survival of early micrometastases
9. Proposal for a new model of breast cancer metastatic development
10. Relationship between disease-free interval and survival in patients with recurrent melanoma
11. Intratumour microvessel density as a pronostic factor in cancer
12. Clinical importance of the determination of tumour angiogenesis in breast carcinoma
13. Analyse moleculaire de l'angiogenese tumorale
14. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumours: Concentration in tumour blood vessels
15. La morphogenese de l'arbre vasculaire. De la comprehension des mecanismes moleculaires aux perspectives therapeutiques
16. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
17. Angiostatin induces and sustains dormancy of human primary tumours in mice
18. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
19. Effects of angiogenesis inhibitors on multistage carcinogenis in mice
20. Rapid growth of cutaneous metastases after surgical resection of thrombospondinsecreting small blue round cell tumour of childhood
21. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer
22. The prognostic significance of tumcur vascularity in intermediate-thickness (0.76-4.0 mmthick) skin melanoma, a quantitative histologic study
23. Prognostic value of high-frequency sonography and color Doppler sonography for th preoperative assessment of melanomas
24. Angiogenesis and tumour progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melenoma
25. Tumor vascularity as a prognostic indicator in intermediate-thickness (0.6-4 mm) cutaneous melanoma.A quantitative assay
26. Angiogenesis correlates with metastasis in melanoma
27. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin
28. Angiogenesis and vascular growth factor receptor expression in malignant melanoma
29. Prognostic value of tumour vascularity in primary melanoma
30. Regression and other factors of prognostic interest in malignant melanoma
31. Thin malignat melanoma(< 1.5 mm) with metastase: A histological study and survival analysis
32. Angiogenesis and regressing cutaneous malignant melanoma
33. Regressing thin cutaneous malignant melanoma (< or = 1.0 mm) are associated with angiogenesis
34. Tumour vascularity, proliferation and apoptosis in human melanoma micrometastases and macrometastases
35. The concept of immunological surveillance
36. Immunobiology of metastases
37. Malignant melanoma: Changings trends in factors influencing metastases-free survival from 1964 to 1982
38. Revesibility of lymphomas an lymphoproliferative lesions developing under cyclosporin steroid therapy
39. The opportunistic tumours of immune deficiency
40. The involment of natural killer cells in human malignant disease
41. Evidence that stress and surgicals interventions promote tumor development by suppressing Natural Killer cell activity
42. Changes in peripheal t-cell subsets and natural-killer cytotoxicity in relation to colorectal cancer surgery
43. Stress and immune responses after surgical treatment for regional breast cancer
44. Natural killer cell activity during premedication, anesthesia and surgery
45. Surgical stress impairs natural killer cell programming of tumor for lysis in patients with sarcomas and others solid tumours
46. Does surgical stress cause tumour metastases?
47. Role of corticosterid hormones in the control of cell proliferation in residual tumor after surgical cytoreduction
48. Antigenes de rejet des tumeurs et immunotherapie specifique du cancer
49. Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp 100 peptide ((280-288), induce pairs of T-cell culture with similar phenotype and lytic activity
50. Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells
51. Molecular detection of circulating solid carcinoma cells in the peripheral blood: The concept of early systemic disease
52. Surgical manipulation of VX2 carcinoma in the rabbit liver evokes enhancement of metastasis
53. Cancer of the colon: The influence of the no-touch isolation technique on survival rates
54. No-touch isolation technic in colon cancer: A controlled prospective trial
55. Detection of melanoma cells in peripheal blood by means of reverse transcriptase and polymerase chain reaction
56. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
57. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma
58. Detection de cellules melaniques circulantes par transcription inverse et reaction de polymerisation en chaine dans les melanomes
59. Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment, and recurrence from melanoma